General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pills1577x362April 20 2016

NICE has issued guidance bringing together legal requirements and existing guidance around the safe use and management of controlled drugs (CDs).

Recommendations in the guidance, NG64, cover:

  • developing and establishing systems and processes for organisations
  • record keeping for organisations
  • risk assessment for organisations
  • processes for reporting controlled drug-related incidents
  • prescribing CDs
  • obtaining and supplying CDs
  • administering CDs
  • handling CDs
  • monitoring the use of CDs.

The new guidance is intended to “help health and social care professionals negotiate complex legislation and regulations to ensure they are doing all they can to care for patients being treated with controlled drugs,” said NICE.

Among the recommendations it has highlighted are:

  • pharmacists should tell patients when only part of their prescription is available, and they should also tell patients when the rest will be ready and how soon they must collect it;
  • doctors should prescribe enough of a controlled drug to meet the person’s clinical needs for up to but no more than 30 days. If, under exceptional circumstances, a larger quantity is prescribed, the reasons for this should be documented in the person’s care record;
  • health professionals should provide advice and information to people prescribed medications about how to store and dispose of them safely – discuss lockable or non-lockable storage boxes, whether drugs will be accessible to others and whether the chosen storage method increases the risk of a drug-related incident;
  • health organisations should keep a record log for the supply, administration, transfer and disposal of controlled drugs.

“Since the Shipman Inquiry's Fourth Report in 2004, the government have introduced significant legislative changes to the Act to strengthen the governance arrangements for CDs,” said NICE. “A lot of work has been done to help ensure that CDs are managed and used safely at a local and national level. However, ongoing activity and vigilance is needed to sustain the positive developments that have been achieved.”

NICE has noted that the risk of death with CDs is far greater than with other medications, according to a seven year review of medicines-related safety incidents concerning CDs in England and Wales. It found that five commonly used CDs were responsible for 113 incidents (88.4%) leading to serious harm (death and severe harm), with overdose accounting for 89 (69.5%) of the 128 incidents of serious harm.

“This guideline provides further clarity and good practice recommendations for the safe use and management of controlled drugs across all NHS settings,” said NICE. “It supports organisations and health and social care practitioners to minimise harms associated with controlled drugs by having robust systems and processes in place. The recommendations were developed with the aim of bringing together legislation, policy advice, good practice advice and published evidence.”

Links:

NICE announcement

NICE guideline NG64 ‘Controlled drugs: safe use and management’

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...